{"id":"https://openalex.org/W104966348","doi":null,"title":"LSD-induced Hallucinogen Persisting Perception Disorder treated with clonazepam: two case reports.","display_name":"LSD-induced Hallucinogen Persisting Perception Disorder treated with clonazepam: two case reports.","alternate_titles":[],"publication_year":2001,"publication_date":"2001-01-01","ids":{"openalex":"https://openalex.org/W104966348","mag":"104966348","pmid":"https://pubmed.ncbi.nlm.nih.gov/11475916"},"language":"en","primary_location":{"id":"pmid:11475916","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11475916","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Israel journal of psychiatry and related sciences","raw_type":"Case Reports"},"parent_works":[],"lineage":["https://openalex.org/W104966348"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101453390","display_name":"A Lerner","orcid":"https://orcid.org/0009-0003-0081-5912","observed_orcids":["https://orcid.org/0009-0003-0081-5912"]},"institutions":[{"id":"https://openalex.org/I4210159594","display_name":"Lev Hasharon Hospital","ror":"https://ror.org/04vcan916","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I4210159594"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"A G Lerner","raw_affiliation_strings":["Lev Hasharon Mental Health Medical Center, Pardessya, Israel. lerneram@internet-zahav.net"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lev Hasharon Mental Health Medical Center, Pardessya, Israel. lerneram@internet-zahav.net","institution_ids":["https://openalex.org/I4210159594"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061371489","display_name":"Irena Skladman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"I Skladman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062393312","display_name":"Arad Kodesh","orcid":"https://orcid.org/0000-0002-8924-1972","observed_orcids":["https://orcid.org/0000-0002-8924-1972"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Kodesh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059750225","display_name":"Mircea Sigal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Sigal","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5056370071","display_name":"Emi Shufman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E Shufman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.1728,"has_fulltext":false,"cited_by_count":27,"citation_normalized_percentile":{"value":0.7829366,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":96},"biblio":{"volume":"38","issue":"2","first_page":"133","last_page":"136"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12553","display_name":"Psychedelics and Drug Studies","score":0.9824000000953674,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T12553","display_name":"Psychedelics and Drug Studies","score":0.9824000000953674,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T13397","display_name":"Hallucinations in medical conditions","score":0.008999999612569809,"subfield":{"id":"https://openalex.org/subfields/2805","display_name":"Cognitive Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.003800000064074993,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hallucinogen-persisting-perception-disorder","display_name":"hallucinogen persisting perception disorder","score":0.9079999923706055},{"id":"https://openalex.org/keywords/lsd","display_name":"LSD","score":0.5649999976158142},{"id":"https://openalex.org/keywords/clonazepam","display_name":"clonazepam","score":0.8799999952316284},{"id":"https://openalex.org/keywords/benzodiazepines","display_name":"benzodiazepines","score":0.9909999966621399},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.5910000205039978}],"concepts":[{"id":"https://openalex.org/C2779426884","wikidata":"https://www.wikidata.org/wiki/Q407988","display_name":"Clonazepam","level":2,"score":0.9898492097854614},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.8575232028961182},{"id":"https://openalex.org/C57992300","wikidata":"https://www.wikidata.org/wiki/Q2066956","display_name":"Potency","level":3,"score":0.6761418581008911},{"id":"https://openalex.org/C37000724","wikidata":"https://www.wikidata.org/wiki/Q50430226","display_name":"Serotonergic","level":4,"score":0.658948540687561},{"id":"https://openalex.org/C124315065","wikidata":"https://www.wikidata.org/wiki/Q194270","display_name":"Hallucinogen","level":2,"score":0.5707692503929138},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4657118618488312},{"id":"https://openalex.org/C2775858608","wikidata":"https://www.wikidata.org/wiki/Q576618","display_name":"Anticonvulsant","level":3,"score":0.4408387839794159},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.42922282218933105},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.35284894704818726},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.28487473726272583},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.2335585057735443},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.21880123019218445},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.18388327956199646},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0510101318359375},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002998","descriptor_name":"Clonazepam","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008238","descriptor_name":"Lysergic Acid Diethylamide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010468","descriptor_name":"Perceptual Disorders","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D010468","descriptor_name":"Perceptual Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D013375","descriptor_name":"Substance Withdrawal Syndrome","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:11475916","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11475916","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Israel journal of psychiatry and related sciences","raw_type":"Case Reports"},{"id":"mag:104966348","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11475916","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2078583994","https://openalex.org/W4414162243","https://openalex.org/W2043470253","https://openalex.org/W4294127245","https://openalex.org/W2129290879","https://openalex.org/W4387216276","https://openalex.org/W3195370529","https://openalex.org/W2464973388","https://openalex.org/W7207645866","https://openalex.org/W2184278236"],"abstract_inverted_index":{"Benzodiazepines":[0],"are":[1],"recommended":[2],"for":[3],"the":[4,81],"treatment":[5,82],"of":[6,42,83],"Hallucinogen":[7],"Persisting":[8],"Perception":[9],"Disorder":[10],"(HPPD),":[11],"although":[12],"it":[13],"is":[14],"unclear":[15],"which":[16,57,70],"may":[17,74],"be":[18,75],"more":[19],"helpful.":[20],"Two":[21],"out-patients":[22],"with":[23,29,86],"LSD-induced":[24,87],"HPPD":[25],"were":[26],"successfully":[27],"treated":[28],"clonazepam.":[30],"They":[31],"had":[32],"not":[33],"responded":[34],"to":[35,77],"low":[36,40],"potency":[37,66],"benzodiazepines":[38,67,79],"or":[39],"doses":[41],"classic":[43],"antipsychotics.":[44],"After":[45],"clonazepam":[46],"discontinuation":[47],"they":[48],"reported":[49],"a":[50,60],"marked":[51],"improvement":[52],"and":[53],"only":[54],"mild":[55],"symptomatology":[56],"persisted":[58],"during":[59],"six":[61],"month":[62],"follow-up":[63],"period.":[64],"High":[65],"like":[68],"clonazepam,":[69],"has":[71],"serotonergic":[72],"properties,":[73],"superior":[76],"low-potency":[78],"in":[80],"some":[84],"patients":[85],"HPPD.":[88]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W104966348","counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
